You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2005 or most recent year available [see all tables in this series...]

Part (i) Demographics of all clients entering treatment

Country		Year	No. of clients	Mean age	% Age <25	% Age 35+	% Male
Bulgaria		2005	1443	24.2	59.2	3.0	83.1
Czech Republic		2005	8041	24.5	57.2	8.4	69.6
Denmark		2005	5228	31.6	27.7	35.4	75.8
Germany		2005	61243	30.2	38.1	27.4	79.0
Ireland		2005	4671	28.2	40.2	14.5	75.4
Greece		2005	4248	29.8	33.6	20.4	84.3
Spain	(1)	2004	52922	32.0	22.1	38.2	83.4
France		2005	20989	28.0	41.3	22.9	80.3
Italy	(2)	2005	48734	32.0	24.4	35.6	86.4
Cyprus		2005	423	27.9	38.5	19.4	86.5
Latvia	(3)	2005	401	22.2	69.6	9.5	76.0
Lithuania		2005	5371	30.2	30.8	23.7	81.4
Luxembourg		2005	383	30.0	30.0	30.0	70.0
Hungary		2005	14793	26.7	42.0	22.0	67.0
Malta		2005	511	24.9	56.2	12.4	86.3
Netherlands		2005	9411	32.9	24.2	40.5	82.2
Austria	(4)	2005	7554	33.8	19.1	46.3
Poland	(1)	2004	12818	29.0	49.8	24.1	76.4
Portugal	(3)	2005	4844	31.0	20.8	36.1	85.3
Romania		2005	1538	32.3	41.0	33.0	70.6
Slovenia	(1)	2004	2902	27.1	39.0	13.0	78.0
Slovakia		2005	2078	25.6	54.1	9.7	79.7
Finland		2005	2935	27.3	45.0	17.0	70.3
Sweden		2005	6750	32.4	26.2	40.3	77.8
United Kingdom	(5)	2005	117781	30.4	29.1	27.8	71.8
Turkey		2005	2057	30.1	30.0	26.0	92.7

Notes:

Data were not available for: Belgium, Estonia, Norway.

(1) Last data available refer to 2004.

(2) Until 2004 under 'all clients' reported clients continuing in or entering treatment in reported year; 2005 data are conformant with the TDI protocol.

(3) Data refer to first treatments.

(4) Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are 100%.

(5) Data relate to the period from 1 April 2004 to 31 March 2005 for UK.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - Standard table 3 See [Table TDI-1 Part (0)] for details on sources.